<DOC>
	<DOCNO>NCT02353923</DOCNO>
	<brief_summary>The purpose study determine whether supplementation OcuStem , nutritional supplement , reduce progression mild moderate diabetic retinopathy .</brief_summary>
	<brief_title>OcuStem Nutritional Supplement Diabetic Patients With Mild Moderate Non-proliferative Retinopathy</brief_title>
	<detailed_description>This research study design evaluate effect nutritional supplement , OcuStem , mild moderate nonproliferative diabetic retinopathy . In condition blood vessel back eye , area term retina , deteriorate . OcuStem contain ingredient previously demonstrate clinical trial stimulate type cell , call `` endothelial progenitor cell '' increase circulation . Animal study show increase endothelial progenitor cell number inhibit progression diabetic retinopathy . The hypothesis study 6 month course OcuStem reduce progression mild moderate diabetic retinopathy .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Age â‰¥ 18 year One study eye per subject may enrol . Diagnosis diabetes mellitus ( type 1 type 2 ) Any one following consider sufficient evidence diabetes present : 1 . Current regular use insulin treatment diabetes 2 . Current regular use oral antihyperglycemia agent treatment diabetes 3 . Documented diabetes ADA and/or WHO criteria . The study eye must meet following : 1 . Presence microaneurysms least mild nonproliferative diabetic retinopathy ( level 20 high ) clinical exam . 2 . No presence centerinvolved diabetic macular edema ( DME ) evidence OCT central subfield thickness &lt; 250 micron ( spectral domain OCT equivalent ) . 3 . Visual acuity light perception well . A current ocular condition , opinion investigator , visual acuity might affect and/or may need treat ( e.g. , DME , foveal atrophy , pigment abnormality , dense subfoveal hard exudate , nonretinal condition ( cataract ) , epiretinal membrane vitromacular traction ) course study ( e.g. , vein occlusion , uveitis ocular inflammatory disease , neovascular glaucoma , etc. ) . A history major ocular surgery ( include vitrectomy , scleral buckle , intraocular surgery , etc . ) within prior 4 month major ocular surgery include cataract removal anticipate within next 4 month follow enrollment . Pregnant Women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>